1369257-58-8

Basic information

• Product Name: (4-(4-chloro-3-(trifluoromethyl)phenoxy)phenyl)methanol
• Synonyms: (4-(4-chloro-3-(trifluoromethyl)phenoxy)phenyl)methanol
• CAS NO: 1369257-58-8
• Molecular Weight: 302.68
• Mol File: 1369257-58-8.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: (4-(4-chloro-3-(trifluoromethyl)phenoxy)phenyl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (4-(4-chloro-3-(trifluoromethyl)phenoxy)phenyl)methanol(1369257-58-8)
• EPA Substance Registry System: (4-(4-chloro-3-(trifluoromethyl)phenoxy)phenyl)methanol(1369257-58-8)

Safety Data

• Hazardous Substances Data: 1369257-58-8(Hazardous Substances Data)

Upstream product

• 6294-93-5 4-chloro-3-trifluoromethylphenol 
• 459-57-4 4-fluorobenzaldehyde 

Downstream Products

• 1359656-24-8 1-(4-(4-chloro-3-(trifluoromethyl)phenoxy)phenyl)methylamine 
• 629647-23-0 2-(4-(4-chloro-3-(trifluoromethyl)phenoxy)benzyl)isoindoline-1,3-dione 
• 1380427-55-3 2-{[(4-{[4-chloro-3-(trifluoromethyl)phenyl]oxy}phenyl)methyl]thio}-5-(1-piperidinylmethyl)-4(1H)-pyrimidinone 
• 1380429-72-0 ethyl 2-{[(4-{[4-chloro-3-(trifluoromethyl)phenyl]oxy}phenyl)methyl]thio}-4-oxo-1,4-dihydro-5-pyrimidinecarboxylate 
• 1380429-70-8 4-(4-(bromomethyl)phenoxy)-1-chloro-2-(trifluoromethyl)benzene 
• 1381792-12-6 4-{[(4-{[4-chloro-3-(trifluoromethyl)phenyl]oxy}phenyl)methyl]oxy}-2(1H)-pyridinone 
• 1381791-46-3 4-{[(4-{[4-chloro-3-(trifluoromethyl)phenyl]oxy}phenyl)methyl]oxy}-1-ethyl-2(1H)-pyridinone 
• 1381791-44-1 C₂₄H₁₉ClF₃N₃O₃ 
• 1369255-78-6 1-chloro-4-(4-(chloromethyl)phenoxy)-2-(trifluoromethyl)benzene 

Relevant articles and documents

Tricyclic dihydroimidazopyrimidinone derivative, and preparation method, pharmaceutical composition and application thereof

The invention provides a compound as shown in a general formula (I), cis-trans isomers, enantiomers, diastereoisomers, racemes, solvates, hydrates or pharmaceutically acceptable salts or prodrugs of the compound, a preparation method of the compound, a pharmaceutical composition containing the compound and an application of the compound as aLp-PLA2 inhibitor, wherein R1, R2, Rx, Ra, Q, U, X, Y, m, n and A are defined in the specification.

Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors

Inhibition of lipoprotein-associated phospholipase A2 (Lp-PLA2) has been suggested to be a promising therapeutic strategy for several inflammation-associated diseases, including atherosclerosis, Alzheimer's disease, and diabetic macu

BICYCLIC PYRIMIDONE COMPOUNDS

The present invention relates to novel bicyclic pyrimidone compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.